in vivo evaluation of [18F]1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine: A Selective sigma-1 receptor radioligand for PET
- 1 February 1997
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 24 (2) , 127-134
- https://doi.org/10.1016/s0969-8051(96)00184-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Synthesis of [18F]-1-(3-Fluoropropyl)-4-(4-cyanophenoxymethyl)-piperidine: A potential sigma-1 receptor radioligand for PETJournal of Labelled Compounds and Radiopharmaceuticals, 1996
- Sigma‐1 and Sigma‐2 sites in rat brain: Comparison of regional, ontogenetic, and subcellular patternsSynapse, 1994
- Regional variation in the ratio of σ1 to σ2 binding in rat brainEuropean Journal of Pharmacology, 1994
- Synthesis and Characterization of [125I]-N-(N-Benzylpiperidin-4-yl)-4-iodobenzamide, a New .sigma. Receptor Radiopharmaceutical: High-Affinity Binding to MCF-7 Breast Tumor CellsJournal of Medicinal Chemistry, 1994
- (+)-[C-11]-cis-N-benzyl-normetazocine: A selective ligand for sigma receptors in vivoLife Sciences, 1994
- Strain differences in rat brain and liver σ binding: lack of cytochrome P450-2D1 involvementEuropean Journal of Pharmacology, 1993
- Synthesis and binding characteristics of potential SPECT imaging agents for .sigma.-1 and .sigma.-2 binding sitesJournal of Medicinal Chemistry, 1993
- Sigma receptors are associated with cortical limbic areas in the primate brainSynapse, 1992
- Novel antipsychotic drugs share high affinity for σ receptorsEuropean Journal of Pharmacology, 1988
- Both the σ receptor-specific ligand(+)3-PPP and the PCP receptor-specific ligand TCP act in the mouse vas deferens via augmentation of electrically evoked norepinephrine releaseEuropean Journal of Pharmacology, 1987